Mortality, disability, and intensive care in patients with mitochondrial 3243A>G mutation
- 400 Downloads
KeywordsIntensive Care Unit Valproate Intensive Care Unit Admission Intensive Care Unit Patient Intensive Care Unit Stay
The authors acknowledge the statistical assistance provided by the Taiwan Clinical Trial Bioinformatics and Statistical Center, Training Center, and Pharmacogenomics Laboratory (founded by the National Research Program for Biopharmaceuticals (NRPB) at the National Science Council of Taiwan; NSC 102-2325-B-002-088), and the Department of Medical Research of National Taiwan University Hospital. The study was supported by grants from the National Science Council of Taiwan (project number NSC 102-2314-B-002 -099) and ResMed Respiratory Medicine Institute Clinical Study Fund.
Conflicts of interest
The authors declare no conflicts of interest.